Sunrakshakk Targets INR1,000 Cr by FY28 on Guwahati Ramp-Up

Sunrakshakk Industries India Limited — Q4 & FY26 Earnings Call (ended 31 Mar 2026)

1. Overall Tone of Management: Optimistic

• Management highlights “strong growth” and “highest ever revenue and profitability” in FY26.
• Repeated confidence in scaling: “gives us confidence in the long-term scalability” and “remain confident about the opportunities before us.”
• Forward-looking targets are stated with relative certainty (e.g., INR1,000 cr by FY28), with limited discussion of downside.

2. Key Themes from Management Commentary

• FMCG scaling as the core growth engine
• FMCG + FMCG intermediates “contribute the majority of our revenues” and are the “primary growth engine.”
• FMCG revenues “crossed the INR500 crores milestone.”
• Manufacturing footprint expansion and ramp-up benefits
• Guwahati facility commissioning/revamp: improved capabilities (soap noodles, cosmetics) and “better capacity utilization.”
• Edible business (spices/savories) scaling from Bhilwara facilities: “started contributing meaningfully.”
• Balance sheet strengthening via preferential issue
• Capital raise “strengthened our balance sheet” and supports “manufacturing capacity, working capital… and future growth.”
• Margin improvement narrative tied to operating efficiencies
• Q4 profitability improvement attributed to “ramp-up of the Guwahati facility,” “better capacity utilization,” and “improved operating efficiencies.”
• Medium-term aspiration
• “approximately INR1,000 crores in revenue by FY28” framed as a milestone, not the end.

3. Q&A Analysis

Theme A: INR1,000 cr (FY28) growth plan & drivers

• Core questions
• What drives the INR1,000 cr target?
• Is it achievable with existing capacity or needs capex?
• Organic vs inorganic contribution?
• Management response
• Drivers: annualized Q4 run-rate (~INR800 cr) + “organic growth of 10%-15%” and adding new customers (soap section).
• Capacity: “can be achieved with the existing capacity” and “we don’t see much of the expansion… in the capex side.”
• Organic vs inorganic: INR1,000 cr can be achieved organically; inorganic is “constantly looking for… acquisition… if lucrative in terms of ROI.”
• Notable / partial / evasive points
• Clarification attempt on the 10–15% growth: management later says it is “over and above the INR800 crore” (suggests earlier framing could confuse).
• No concrete inorganic plan (segments/geographies are broadly stated).

Theme B: Margins—sustainability and path to targets

• Core questions
• Why margins are down Y-o-Y; what sustainable EBITDA/PAT margins can be?
• Can they reach PAT ~7% in FY27?
• What operating leverage to expect?
• Management response
• Margin dip attributed to “product mix”; segment-wise improvement claimed.
• Internal target: “PAT at the rate 7% in the near future.”
• FY27: “we will be nearby to the target.”
• Operating leverage: improved capacity utilization; management suggests ~“another 1, 1.25%” PAT improvement from better utilization/absorption.
• Notable / unusually strong answers
• Confidence that margin improvement is largely mechanical from utilization, with limited discussion of pricing power, input costs, or competitive intensity.

Theme C: Segment outlook (Guwahati performance, edibles size, FMCG vs edible mix)

• Core questions
• How is Guwahati performing and customer response?
• How big can edibles become in 3–5 years?
• Which FMCG categories have strongest demand?
• Management response
• Guwahati: “doing very well,” production increasing gradually; “product acceptance is quite well.”
• Edibles: spices & savories growing; expects “growth of 20%” and FMCG remains lead contributor; edibles “substantial share” but not top.
• FMCG categories: “personal care and home care” are key contributors.
• Notable / partial points
• Edibles “size” is discussed qualitatively; only growth rate is given (no explicit revenue share target).

Theme D: Working capital / risk factors

• Core questions
• Debtor cycle stability despite growth?
• Raw material price risk (war-related)?
• Any capacity constraints?
• Management response
• Debtor cycle: “stable, it’s not increasing.”
• Raw materials: “bit pressure” on pricing, but “supplies… right on time” due to strategic supplier selection.
• Capacity constraints: “no constraint right as of now,” spare capacities exist.
• Notable / partial points
• “No risk” language is used for topline achievement; risk discussion is limited.

Theme E: B2B vs B2C, branding, and advertising

• Core questions
• Are they only B2B? Any B2C plans?
• What is “Swechha” brand—who owns it?
• Will they advertise to improve market presence?
• Management response
• B2B now; B2C only “in a longer run” with good partners; “not in the immediate future.”
• “Swechha” is owned by a customer; they manufacture for multiple brands (ITC, Godrej, Patanjali, Jyothy, etc.).
• Advertising: “not much of the need” in B2B; “not going to happen in near future,” though one investor suggestion was acknowledged (“Let’s see what we can do”).
• Notable / evasive points
• Advertising question is partially deflected into B2B logic; no clear alternative marketing strategy is provided.

Theme F: Preferential issue utilization

• Core questions
• Where did preferential issue proceeds go?
• Management response
• Mostly for edible manufacturing expansion and FMCG Guwahati unit.
• Mentions tentative splits: “55 crores” utilized for FMCG segment; “10 crores FD” available; remaining for edible section.
• Notable / partial points
• Numbers are described as “tentatively,” implying some lack of precision.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Revenue
• “approximately INR1,000 crores in revenue by FY28.”
• Organic growth expectation: “10%-15%” (later clarified as “over and above the INR800 crore” annualized run-rate).
• Margins / profitability
• PAT target: “PAT at the rate 7% in the near future.”
• FY27: “nearby to the target” (implies approaching 7%).
• FY28 EBITDA margin improvement: “improvement of around 1%, 1.5% in the existing EBITDA margins.”
• Segment growth
• Edibles: “growth of 20%” (no revenue share given).
• FMCG intermediates growth: “15 to 20% kind of” in coming year.
• Capacity utilization
• Guwahati utilization: “45% to 50%” (cosmetics) and “45% to 55%” (soap noodles/capacity).

Implicit signals (qualitative)

• Capex discipline: management repeatedly indicates limited incremental capex needed to reach INR1,000 cr.
• Margin improvement thesis: relies heavily on capacity utilization and operating leverage, not on pricing or cost inflation relief.
• Inorganic optionality: acquisitions are “constantly looking” but not committed.

5. Standout Statements (direct / high-signal)

• “FMCG revenues crossed the INR500 crores milestone.”
• “The improvement in profitability… reflects the early outcome” of operating efficiency efforts.
• “INR1,000 crores turnover can be achieved with the existing capacity.”
• “We are aiming a PAT of 7%… and we are working on it.”
• “In FY27, we will be nearby to the target.”
• “No, we are not forcing any such kind of risk in achieving that topline by 2028.”
• Capacity utilization disclosure: “45% to 50%” (cosmetics) and “45% to 55%” (soap noodles).
• Advertising stance: “in B2B… there is not much of the need for any kind of publicity and advertisement.”

6. Red Flags / Positive Signals

Red flags
– Margin guidance is utilization-centric with limited discussion of input cost volatility, pricing power, or competitive dynamics.
– “No risk” language on achieving topline by FY28 (“not forcing any such kind of risk”) may be overly absolute.
– Some guidance clarity issues:
– Organic growth framing required clarification (“10–15% over and above INR800 cr”).
– Preferential issue utilization includes “tentatively” and mixed figures, suggesting incomplete precision.

Positive signals
– Operational ramp-up is evidenced: Q4 is described as strongest quarter with sequential improvement in margins.
– Working capital discipline: debtor cycle “stable” despite strong growth.
– Customer traction: Guwahati “doing very well” with “product acceptance quite well.”
– No stated capacity constraints and disclosed utilization ranges.

7. Historical Comparison & Consistency Analysis (vs prior calls)

Only one prior transcript is provided (Q3 & 9M FY26 call on 16 Feb 2026). So “3–4 calls” comparison is limited.

a. Change in Tone Over Time

• Shift: More Optimistic
• Prior call: transformation narrative + ramp-up expectations; margins discussed with more cautious “aiming” language.
• Current call: stronger achievement framing (“highest ever revenue and profitability,” “strong growth,” “results… clearly visible”).
• What changed
• More confidence in execution: INR1,000 cr target is reiterated with “existing capacity” claim.
• Margin improvement now tied to already observed Q4 profitability improvement, not just future operating leverage.

b. Tracking Past Commitments vs Outcomes

• Past statement (Feb 2026): “commissioned in January 2026” and scaling FMCG; target of INR1,000 cr by FY28 reiterated.
• What was expected: ramp-up of Guwahati and improved utilization to drive growth/margins.
• What happened (current call):
• Guwahati ramp-up cited as a driver of Q4 margin improvement (“ramp-up… from January 2026”).
• FMCG now “crossed INR500 crores milestone.”

• Assessment: ✅ Delivered / on track for the Guwahati ramp-up narrative and growth momentum.

• Past statement (Feb 2026): PAT target of ~7% by FY28 (and margin improvement via operating leverage/automation).

• Current call: PAT 7% reiterated; FY27 “nearby to target.”
• Assessment: ⏳ In progress (no proof of reaching 7% yet; only trajectory).

c. Narrative Shifts

• Textile down-weighting becomes more explicit
• Feb call: textile still present; FMCG expected to rise.
• Current call: textile share expected to fall to “10% to 12% max” and no de-merger plans.
• Advertising/brand narrative
• Feb call leaned into manufacturing/B2B; current call repeats B2B logic but acknowledges investor suggestion.
• Margin explanation evolves
• Feb: margin improvement via scale, cost optimization, automation.
• Current: margin dip mainly “product mix,” and improvement via utilization absorption.

d. Consistency & Credibility Signals

• Medium credibility
• Consistent strategic direction: FMCG-led integrated manufacturing + B2B customer base.
• Some credibility risk from:
  • “No risk” statement on topline achievement.
  • Margin improvement reliance on utilization without addressing potential downside drivers (pricing/input costs/competition) in detail.
• However, Q4 sequential improvement and Guwahati ramp-up attribution support the narrative.

e. Evolution of Key Themes

• Demand / growth: Improving/stable—management now cites milestones (INR500 cr FMCG) rather than only plans.
• Margins: Mixed—FY26 EBITDA margin is stated as down vs FY25 (9.66% vs 14.24%), but Q4 shows improvement; management attributes to mix and expects PAT stabilization at 7%.
• Expansion / capex: More disciplined tone—current call emphasizes “existing capacity” to reach INR1,000 cr, whereas Feb call discussed capacity additions and planning.

f. Additional Insights (cross-period intelligence)

• The company’s growth is now supported by disclosed utilization ranges (45–55%), implying they are not yet at full capacity. This makes the PAT 7% target dependent on further utilization ramp—consistent with their operating leverage thesis, but also a key execution dependency.
• The FY26 EBITDA margin decline vs FY25 (despite “highest ever profitability”) suggests profitability improvement may be driven more by scale/revenue growth than by sustained EBITDA margin expansion—management now shifts focus to PAT margin rather than EBITDA.